Polymer-Peptides Hybrids: Grove Biopharma Targets Undruggable Diseases!
Grove Biopharma uses protein-like polymers to deliver peptides inside cells, opening the door to drug targets that have long been considered unreachable.
By combining quantum chemistry with generative AI, researchers designed metal-dependent enzymes that approach the efficiency of nature's own catalysts.
